{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:40:36Z","timestamp":1759639236860,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"DOI":"10.7759\/cureus.93844","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:59:26Z","timestamp":1759636766000},"source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Epilepsy Secondary to CASPR2 Antibody Encephalitis: A Case Report Highlighting Diagnostic Challenges and Management"],"prefix":"10.7759","author":[{"given":"Fenghui","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Suski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-823912-4.00009-8","article-title":"Autoimmune and paraneoplastic seizures","volume":"200","author":"Wagner B","year":"2024","unstructured":"Wagner B, Irani S. Autoimmune and paraneoplastic seizures. Handb Clin Neurol. 2024, 200:151-72. 10.1016\/B978-0-12-823912-4.00009-8","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(00)81049-1","article-title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels","volume":"24","author":"Poliak S","year":"1999","unstructured":"Poliak S, Gollan L, Martinez R, et al.. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron. 1999, 24:1037-47. 10.1016\/s0896-6273(00)81049-1","journal-title":"Neuron"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14081","article-title":"Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases","volume":"48","author":"Saint-Martin M","year":"2018","unstructured":"Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J. Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci. 2018, 48:1906-23. 10.1111\/ejn.14081","journal-title":"Eur J Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster E","year":"2016","unstructured":"Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016, 12:1-13. 10.3988\/jcn.2016.12.1.1","journal-title":"J Clin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome","volume":"267","author":"Boyko M","year":"2020","unstructured":"Boyko M, Au KL, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol. 2020, 267:1137-46. 10.1007\/s00415-019-09686-2","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related Morvan syndrome: autonomic, polysomnographic, and neuropsychological observations","volume":"11","author":"Swayang PS","year":"2021","unstructured":"Swayang PS, Nalini A, Preethish-Kumar V, et al.. CASPR2-related Morvan syndrome: autonomic, polysomnographic, and neuropsychological observations. Neurol Clin Pract. 2021, 11:e267-76. 10.1212\/CPJ.0000000000000978","journal-title":"Neurol Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/epd2.20269","article-title":"CASPR2-related epilepsy: a distinctive and unrecognized form of epilepsy in adult and elderly males","volume":"26","author":"Michelucci R","year":"2024","unstructured":"Michelucci R, Pasini E, Riguzzi P, et al.. CASPR2-related epilepsy: a distinctive and unrecognized form of epilepsy in adult and elderly males. Epileptic Disord. 2024, 26:753-60. 10.1002\/epd2.20269","journal-title":"Epileptic Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani SR","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM, et al.. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain. 2013, 136:3151-62. 10.1093\/brain\/awt212","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert B","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N, et al.. Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol. 2016, 73:1115-24. 10.1001\/jamaneurol.2016.1585","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study","volume":"12","author":"Qin X","year":"2021","unstructured":"Qin X, Yang H, Zhu F, Wang Q, Shan W. Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study. Front Immunol. 2021, 12:652864. 10.3389\/fimmu.2021.652864","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen A","year":"2016","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, et al.. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016, 87:521-8. 10.1212\/WNL.0000000000002917","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2024.16","article-title":"Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults","author":"Hahn C","year":"2024","unstructured":"Hahn C, Budhram A, Alikhani K, et al.. Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults. Can J Neurol Sci. 2024, 1-21. 10.1017\/cjn.2024.16","journal-title":"Can J Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13032-0","article-title":"Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2","volume":"272","author":"Rittel JC","year":"2025","unstructured":"Rittel JC, Hudasch D, Doppler K, et al.. Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2. J Neurol. 2025, 272:287. 10.1007\/s00415-025-13032-0","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks SN","year":"2018","unstructured":"Binks SN, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018, 89:526-34. 10.1136\/jnnp-2017-315720","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth A","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, et al.. Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol. 2017, 82:79-92. 10.1002\/ana.24979","journal-title":"Ann Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2014pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster E","year":"2012","unstructured":"Lancaster E, Dalmau J. Neuronal autoantigens\u2014pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012, 8:380-90. 10.1038\/nrneurol.2012.99","journal-title":"Nat Rev Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17164","article-title":"CASPR2-IgG-associated autoimmune seizures","volume":"63","author":"Garrido Sanabria ER","year":"2022","unstructured":"Garrido Sanabria ER, Zahid A, Britton J, et al.. CASPR2-IgG-associated autoimmune seizures. Epilepsia. 2022, 63:709-22. 10.1111\/epi.17164","journal-title":"Epilepsia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2023.0242","article-title":"Outcome and sequelae of autoimmune encephalitis","volume":"20","author":"Kvam KA","year":"2024","unstructured":"Kvam KA, Stahl JP, Chow FC, Soldatos A, Tattevin P, Sejvar J, Mailles A. Outcome and sequelae of autoimmune encephalitis. J Clin Neurol. 2024, 20:3-22. 10.3988\/jcn.2023.0242","journal-title":"J Clin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/08916930701619490","article-title":"Autoantibody-mediated disorders of the central nervous system","volume":"41","author":"Irani S","year":"2008","unstructured":"Irani S, Lang B. Autoantibody-mediated disorders of the central nervous system. Autoimmunity. 2008, 41:55-65. 10.1080\/08916930701619490","journal-title":"Autoimmunity"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-023-02174-5","article-title":"Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature","volume":"123","author":"Cheng YK","year":"2023","unstructured":"Cheng YK, Ling YZ, Yang CF, Li YM. Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature. Acta Neurol Belg. 2023, 123:1663-78. 10.1007\/s13760-023-02174-5","journal-title":"Acta Neurol Belg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415475-autoimmune-epilepsy-secondary-to-caspr2-antibody-encephalitis-a-case-report-highlighting-diagnostic-challenges-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:59:30Z","timestamp":1759636770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415475-autoimmune-epilepsy-secondary-to-caspr2-antibody-encephalitis-a-case-report-highlighting-diagnostic-challenges-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.93844","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,4]]}}}